Herbas VPB

Print
EN | LT
LT - Imidazotiadiazolo ir imidazopirazino dariniai kaip proteazę aktyvinančio receptoriaus 4 (PAR4) inhibitoriai, skirti gydyti trombocitų agregaciją
EN - IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 519/00 (2006.01)
A61K 31/433 (2006.01)
C07D 513/04 (2006.01)
A61K 31/5025 (2006.01)
C07D 487/04 (2006.01)
A61K 31/4355 (2006.01)
A61P 7/02 (2006.01)
European patent
(11) Number of the document 3243826
(13) Kind of document T
(96) European patent application number 17172927.0
Date of filing the European patent application 2013-04-24
(97) Date of publication of the European application 2017-11-15
(45) Date of publication and mention of the grant of the patent 2019-10-30
(46) Date of publication of the claims translation 2019-12-27
Priority applications
(30) Number Date Country code
201261638577 P 2012-04-26 US
201361787680 P 2013-03-15 US
Inventors
(72)
BANVILLE, Jacques, CA
RÉMILLARD, Roger, CA
RUEDIGER, Edward H., CA
DEON, Daniel H., US
GAGNON, Marc, CA
DUBÉ, Laurence, CA
GUY, Julia, CA
PRIESTLEY, Eldon Scott, US
POSY, Shoshana L., US
MAXWELL, Brad D., US
WONG, Pancras C., US
LAWRENCE, Michael R., US
MILLER, Michael M., US
Grantee
(73) Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US
Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montréal QC H3T 1J4, CA
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Imidazotiadiazolo ir imidazopirazino dariniai kaip proteazę aktyvinančio receptoriaus 4 (PAR4) inhibitoriai, skirti gydyti trombocitų agregaciją
  IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION
Last renewal fee
Payment date Validity (years) Amount
2025-05-19 13 433.50 EUR
Next renewal fee
2026-04-24